Previous close | 3.2000 |
Open | 3.0500 |
Bid | 0.7000 |
Ask | 3.2000 |
Strike | 32.50 |
Expiry date | 2024-10-18 |
Day's range | 3.0500 - 3.2000 |
Contract range | N/A |
Volume | |
Open interest | 10 |
Amgen's (AMGN) Blincyto is now approved for the treatment of adult and pediatric patients one month and older with Philadelphia chromosome-negative B-ALL in the consolidation phase, regardless of MRD status.
We can readily understand why investors are attracted to unprofitable companies. Indeed, Twist Bioscience ( NASDAQ:TWST...
Here is how DaVita HealthCare (DVA) and Twist Bioscience (TWST) have performed compared to their sector so far this year.